You're right, NO it doesn't matter which treatment

You're right, NO it doesn't matter which treatment for whom is approved first, all that matters is approval.

Next point: I can only speak for myself, but I think many of us probably expected too much with this CC and when it failed to live up to our expectations that were set by the very promising sounding PR for the CC, we took a fall from the high perch where our hopes rested.

Aside from the over-hype, there's still some conflicting news within the CC. For instance, I can't understand why the EUA for MM was rejected by the FDA for not being a critical need population, which is very understandable in retrospect, (wished that thought crossed my mind before elevating my hopes too high) but then why is the FDA pushing them to do a P3 M/M trial?

Aside from these points, I need to come clean on this - I regurgitated a bogus statement made several times by other posters that Dr. Lalezari was unaware the FDA wasn't interested in the EUA for M/M and that he was not apprised by NP, so I apologize to anyone I mislead since he never said anything at the CC that I heard. I know better and should have verified my source of info before running my mouth. BAD retired journalist!